feed,title,long_url,short_url
Benzinga,Myovant/Pfizer's Relugolix Combo Therapy Shows Sustained Clinical Benefit In Uterine Fibroids,https://benzinga.com/general/biotech/21/03/20316773/myovantpfizers-relugolix-combo-therapy-shows-sustained-clinical-benefit-in-uterine-fibroids,https://j.mp/2NLlYts
